454 related articles for article (PubMed ID: 28599212)
1. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.
Childs E; Lutz JA; de Wit H
Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212
[TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine upon psychosocial stress responses.
Childs E; Bershad AK; de Wit H
J Psychopharmacol; 2016 Jul; 30(7):608-15. PubMed ID: 27235381
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
Lundahl LH; Greenwald MK
Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the subjective effects of oral Δ
Fogel JS; Kelly TH; Westgate PM; Lile JA
Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348
[TBL] [Abstract][Full Text] [Related]
6. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ
Boggs DL; Cortes-Briones JA; Surti T; Luddy C; Ranganathan M; Cahill JD; Sewell AR; D'Souza DC; Skosnik PD
J Psychopharmacol; 2018 Dec; 32(12):1308-1318. PubMed ID: 30255720
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
8. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.
Pabon E; Rockwood F; Norman GJ; de Wit H
Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis.
Spindle TR; Martin EL; Grabenauer M; Woodward T; Milburn MA; Vandrey R
J Psychopharmacol; 2021 Jul; 35(7):786-803. PubMed ID: 34049452
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
[TBL] [Abstract][Full Text] [Related]
12. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
[TBL] [Abstract][Full Text] [Related]
13. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
14. Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users.
Kowal MA; Hazekamp A; Colzato LS; van Steenbergen H; van der Wee NJ; Durieux J; Manai M; Hommel B
Psychopharmacology (Berl); 2015 Mar; 232(6):1123-34. PubMed ID: 25288512
[TBL] [Abstract][Full Text] [Related]
15. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK
J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495
[TBL] [Abstract][Full Text] [Related]
16. Δ
Doss MK; Weafer J; Gallo DA; de Wit H
Biol Psychiatry; 2018 Nov; 84(10):743-750. PubMed ID: 29884456
[TBL] [Abstract][Full Text] [Related]
17. Marijuana withdrawal in humans: effects of oral THC or divalproex.
Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
[TBL] [Abstract][Full Text] [Related]
18. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.
Spindle TR; Zamarripa CA; Russo E; Pollak L; Bigelow G; Ward AM; Tompson B; Sempio C; Shokati T; Klawitter J; Christians U; Vandrey R
Drug Alcohol Depend; 2024 Apr; 257():111267. PubMed ID: 38498958
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of THC on time perception in frequent and infrequent cannabis users.
Sewell RA; Schnakenberg A; Elander J; Radhakrishnan R; Williams A; Skosnik PD; Pittman B; Ranganathan M; D'Souza DC
Psychopharmacology (Berl); 2013 Mar; 226(2):401-13. PubMed ID: 23179965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
